MacroGenics, Inc.
MGNX
$1.39
$0.1310.32%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 19.35M | 110.71M | 10.80M | 9.10M | 10.72M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.35M | 110.71M | 10.80M | 9.10M | 10.72M |
| Cost of Revenue | 44.38M | 42.41M | 6.09M | 48.15M | 47.51M |
| Gross Profit | -25.03M | 68.30M | 4.71M | -39.04M | -36.79M |
| SG&A Expenses | 27.81M | 14.10M | 14.42M | 14.71M | 12.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 72.19M | 56.52M | 68.98M | 62.85M | 60.07M |
| Operating Income | -52.84M | 54.19M | -58.18M | -53.75M | -49.35M |
| Income Before Tax | -14.48M | 56.31M | -55.66M | -52.19M | -46.07M |
| Income Tax Expenses | 944.00K | -- | -- | -- | -- |
| Earnings from Continuing Operations | -15.42M | 56.31M | -55.66M | -52.19M | -46.07M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.42M | 56.31M | -55.66M | -52.19M | -46.07M |
| EBIT | -52.84M | 54.19M | -58.18M | -53.75M | -49.35M |
| EBITDA | -50.78M | 56.03M | -56.37M | -51.91M | -47.45M |
| EPS Basic | -0.25 | 0.90 | -0.89 | -0.84 | -0.74 |
| Normalized Basic EPS | -0.51 | 0.56 | -0.56 | -0.52 | -0.46 |
| EPS Diluted | -0.25 | 0.90 | -0.89 | -0.84 | -0.75 |
| Normalized Diluted EPS | -0.51 | 0.56 | -0.56 | -0.52 | -0.46 |
| Average Basic Shares Outstanding | 62.78M | 62.74M | 62.66M | 62.29M | 62.04M |
| Average Diluted Shares Outstanding | 62.78M | 62.87M | 62.66M | 62.29M | 62.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |